Clinical Trial Results: Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral levonorgestrel plus meloxicam (IG-002) showing delays ovulation by seven days in normal menstruating women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Prevention

Drugs mentioned

• IG-002 (oral levonorgestrel plus meloxicam) (levonorgestrel; meloxicam)

Snippet

Sponsor: InnovaGyn, Inc. | Conditions: Pregnancy Prevention | Phase 2 | Status: COMPLETED | Results posted: 2026-06-17